US 10183927
Crystalline forms of C21H22Cl2N4O2
granted A61KA61K31/4439A61K45/06
Quick answer
US patent 10183927 (Crystalline forms of C21H22Cl2N4O2) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/4439, A61K45/06, A61P, A61P35/00